课题基金 / 基金详情

Analysis of Th1, Th2, Tc1 and Tc2 cells of patients with otolaryngological diseases.

Analysis of Th1, Th2, Tc1 and Tc2 cells of patients with otolaryngological diseases.
耳鼻喉科疾病患者Th1、Th2、Tc1、Tc2细胞分析
批准号:
16591697
负责人:
OHTA Nobuo
金额:
$1.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

OHTA Nobuo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cytokines are important regulatory mediators secreted by T cells and other immunoactive cells. Based on the cytokine synthesis patterns, CD4 T cells can often be classified into at least two populations with different immune regulatory functions. Th1 cells, producing IL-2 and IFN-γ, are often associated with cell-mediated immune responses such as DTH, whereas Th2 cells, secreting IL-4, IL-5, IL-13, usually provide B cell help and enhance allergic reactions. Naive CD8 T cells, similar to CD4 T cells, can differentiate into at least two subsets of cytolytic effector cells with distinct cytokine patterns. Tc1 cells secrete a Th1-like cytokine pattern, including IL-2 and IFN-γ^^~. Tc2 cells produce Th2 cytokines, including IL-4, IL-5 and Il-10. There is increasing evidence that Th1/Th2 and Tc1/Tc2 cytokine imbalance has been of pathogenetic importance in various diseases, such as allergic and autoimmune diseases. The present review article focuses on the evidence that the imbalance of Th1/Th2 and Tc1/Tc2 cytokines play important role in various otolaryngological diseases, such as Kimura's disease, Wegener's granulomatosism, acute perceptive hearing loss and Menier's disease. It is concluded that the predominance of Th1 and Th2 and Tc1 and Tc2 cells might contribute to the mechanism in pathogenesis of these otolaryngological diseases.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
Th1, Th2, Tc1 and Tc2 cells of patients with allergic rhinitis.
过敏性鼻炎患者的Th1、Th2、Tc1和Tc2细胞。
DOI: --
发表时间: 2005
期刊: Allergy Clinical Immunol Int. 1
影响因子: --
作者: [柳田 薫, 種市明代, 島田和彦, 松林秀彦, Ohta N他]
通讯作者: Ohta N他
Th1,Th2,Tc1 and Tc2 cells of patients with allergic rhinitis.
变应性鼻炎患者的Th1、Th2、Tc1、Tc2细胞。
DOI: --
发表时间: 2005
期刊: Allergy Clinical Immunol Int. 1
影响因子: --
作者: [Oridate N, Kim HJ, Xu X, Lotan R., 〓田薫, Ohta N 他]
通讯作者: Ohta N 他
Th1 and Th2 CD4 and Tc1 and Tc2 CD8 T cells of patients with Wegener's granulomatosis.
韦格纳肉芽肿病患者的 Th1 和 Th2 CD4 以及 Tc1 和 Tc2 CD8 T 细胞。
DOI: --
发表时间: 2005
期刊: Allergy Clinical Immunol Int. 1
影响因子: --
作者: [Kino Y, Kojima F, Kiguchi K, Igarashi R, Ishizuka B, Kawai S, 〓田薫, Ohta N他]
通讯作者: Ohta N他
Analysis of Th1, Th2, Tc1 and Tc2 cells of patients with allergic rhinitis.
变应性鼻炎患者Th1、Th2、Tc1、Tc2细胞分析
DOI: --
发表时间: 2005
期刊: Clin Exp Allergy 5
影响因子: --
作者: [Murakami S, Shirota T, Hayashi S, Ishizuka B, Ohta N他]
通讯作者: Ohta N他
Identification and functional analysis of the sensor system involved in behavioral regulation of larvae of digenic platyhelminthes.
  • 批准号:
    23659209
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.41万
  • 财政年份:
    2011
  • 负责人:
    OHTA Nobuo
  • 依托单位:
The study of pathogenesis and related molecules of IgG4 related disease and development of treatment modality.
  • 批准号:
    22591905
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2010
  • 负责人:
    OHTA Nobuo
  • 依托单位:
Development of surveillance tools for eradication of schistosomiasis japonica applicable for the endemic areas in China
  • 批准号:
    21406008
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.57万
  • 财政年份:
    2009
  • 负责人:
    OHTA Nobuo
  • 依托单位:
Steroids in nasal allergy : its efficacy and resistance
  • 批准号:
    19591955
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.5万
  • 财政年份:
    2007
  • 负责人:
    OHTA Nobuo
  • 依托单位:
国内基金
海外基金
肠道菌群代谢产物SCFA调控Th1/Th2失衡在儿童过敏性鼻炎中的作用及益生菌靶向干预研究
  • 批准号:
    2026JJ82542
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    谢骏
  • 依托单位:
基于TSLP-OX40L/Th2通路探讨吸入性过敏原组分在儿童过敏性鼻炎中的致敏机制与临床应用
  • 批准号:
    2026JJ82154
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    罗伶俐
  • 依托单位:
肺滤泡成熟B细胞在哮喘Th2反应中的作用及机制探讨
  • 批准号:
    JCZRLH202600711
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
基于“金虚宜敛”理论探讨过敏煎经“共生菌-肠肺轴-Th1/Th2免疫失衡”途径防治哮喘的药效机制
  • 批准号:
    JCZRLH202600644
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: